NCT00123643View on ClinicalTrials.gov

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

rosiglitazone

DRUG

glyburide

Trial Locations (1)

55102

St. Paul Heart Clinic, Saint Paul

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

St. Paul Heart Clinic

OTHER